Factors that contribute to disparities in time to acute leukemia diagnosis in young people: an in depth qualitative interview study
- PMID: 35550034
- PMCID: PMC9095817
- DOI: 10.1186/s12885-022-09547-8
Factors that contribute to disparities in time to acute leukemia diagnosis in young people: an in depth qualitative interview study
Abstract
Background: Racial and ethnic disparities in outcomes for Black and Hispanic children with acute leukemia have been well documented, however little is known about the determinants of diagnostic delays in pediatric leukemia in the United States. The primary objective of this study is to identify factors contributing to delays preceding a pediatric leukemia diagnosis.
Methods: This qualitative study utilized in-depth semi-structured interviews. Parents and/or patients within two years of receiving a new acute leukemia diagnosis were asked to reflect upon their family's experiences preceding the patient's diagnosis. Subjects were purposively sampled for maximum variation in race, ethnicity, income, and language. Interviews were analyzed using inductive theory-building and the constant comparative method to understand the process of diagnosis. Chart review was conducted to complement qualitative data.
Results: Thirty-two interviews were conducted with a diverse population of English and Spanish speaking participants from two tertiary care pediatric cancer centers. Parents reported feeling frustrated when their intuition conflicted with providers' management decisions. Many felt laboratory testing was not performed soon enough. Additional contributors to delays included misattribution of vague symptoms to more common diagnoses, difficulties in obtaining appointments, and financial disincentives to seek urgent or emergent care. Reports of difficulty obtaining timely appointments and financial concerns were disproportionately raised among low-income Black and Hispanic participants. Comparatively, parents with prior healthcare experiences felt better able to navigate the system and advocate for additional testing at symptom onset.
Conclusions: While there are disease-related factors contributing to delays in diagnosis, it is important to recognize there are multiple non-disease-related factors that also contribute to delays. Evidence-based approaches to reduce outcome disparities in pediatric cancer likely need to start in the primary care setting where timeliness of diagnosis can be addressed.
Keywords: Disparities; Leukemia; Pediatric oncology; Qualitative research; Race/Ethnicity.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Stroke. 2011 Jul;42(7):2091-116. doi: 10.1161/STR.0b013e3182213e24. Epub 2011 May 26. Stroke. 2011. PMID: 21617147
-
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809. JBI Database System Rev Implement Rep. 2015. PMID: 26447011
-
Association Between Race/Ethnicity and Disparities in Health Care Use Before First-Episode Psychosis Among Privately Insured Young Patients.JAMA Psychiatry. 2021 Mar 1;78(3):311-319. doi: 10.1001/jamapsychiatry.2020.3995. JAMA Psychiatry. 2021. PMID: 33355626 Free PMC article.
-
Racial and Ethnic Differences in Acute Coronary Syndrome and Myocardial Infarction Within the United States: From Demographics to Outcomes.Clin Cardiol. 2016 May;39(5):299-306. doi: 10.1002/clc.22524. Epub 2016 Mar 30. Clin Cardiol. 2016. PMID: 27028198 Free PMC article. Review.
-
Addressing Disparities in Acute Stroke Management and Prognosis.J Am Heart Assoc. 2024 Apr 2;13(7):e031313. doi: 10.1161/JAHA.123.031313. Epub 2024 Mar 26. J Am Heart Assoc. 2024. PMID: 38529656 Free PMC article. Review.
Cited by
-
Perspectives of Caregivers on Access to Health Care for Children with CKD.Kidney Int Rep. 2024 Sep 2;9(11):3177-3189. doi: 10.1016/j.ekir.2024.08.029. eCollection 2024 Nov. Kidney Int Rep. 2024. PMID: 39534191 Free PMC article.
References
-
- American Cancer Society: Survival Rates for Childhood Leukemias. Atlanta: American Cancer Society. [updated 2019 Feb 12; cited 2020 May 26]. Available from: www.cancer.org/cancer/leukemia-in-children/detection-diagnosis-staging/s...
-
- Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, et al. Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III children's oncology group trial AAML05310. J Clin Oncol. 2014;32:3021–3032. doi: 10.1200/JCO.2014.55.3628. - DOI - PMC - PubMed